{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:14:46Z","timestamp":1791530086820,"version":"4.3.4"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Judith & Stewart Colton Center for Autoimmunity"},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY031383"],"award-info":[{"award-number":["R01EY031383"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY033495"],"award-info":[{"award-number":["R01EY033495"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016003","name":"Istanbul \u00dcniversitesi-Cerrahpasa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1136\/ard-2022-222277","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T13:25:44Z","timestamp":1659533144000},"page":"1603-1611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Beh\u00e7et's disease risk-variant HLA-B51\/ERAP1-Hap10 alters human CD8 T cell immunity"],"prefix":"10.1016","volume":"81","author":[{"given":"Ann","family":"Cavers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias Christian","family":"Kugler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Ozguler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshed Fahad","family":"Al-Obeidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1952-1135","authenticated-orcid":false,"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrix M","family":"Ueberheide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didar","family":"Ucar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Manches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-6830","authenticated-orcid":false,"given":"Johannes","family":"Nowatzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2022-222277_bib1","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1073\/pnas.1406575111","article-title":"Beh\u00e7et disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity","volume":"111","author":"Ombrello","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2022-222277_bib2","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ng.625","article-title":"Genome-Wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Beh\u00e7et's disease","volume":"42","author":"Remmers","year":"2010","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2022-222277_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","article-title":"Genome-Wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et's disease susceptibility loci","volume":"42","author":"Mizuki","year":"2010","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2022-222277_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-08923-6","article-title":"Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci","volume":"10","author":"Dudding","year":"2019","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2022-222277_bib5","first-page":"1078","article-title":"Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's disease","volume":"335","year":"1990","journal-title":"Lancet"},{"key":"10.1136\/ard-2022-222277_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","article-title":"Uveitis in Beh\u00e7et disease: an analysis of 880 patients","volume":"138","author":"Tugal-Tutkun","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1136\/ard-2022-222277_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s004150170242","article-title":"Beh\u00e7et's disease: diagnostic and prognostic aspects of neurological involvement","volume":"248","author":"Siva","year":"2001","journal-title":"J Neurol"},{"key":"10.1136\/ard-2022-222277_bib8","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/rheumatology\/keu233","article-title":"Vascular involvement in Beh\u00e7et's syndrome: a retrospective analysis of associations and the time course","volume":"53","author":"Tascilar","year":"2014","journal-title":"Rheumatology"},{"key":"10.1136\/ard-2022-222277_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ng.2520","article-title":"Genome-Wide association analysis identifies new susceptibility loci for Beh\u00e7et's disease and epistasis between HLA-B*51 and ERAP1","volume":"45","author":"Kirino","year":"2013","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2022-222277_bib10","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1136\/annrheumdis-2015-209059","article-title":"A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Beh\u00e7et's disease in HLA-B*51 carriers","volume":"75","author":"Takeuchi","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2022-222277_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature01074","article-title":"ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum","volume":"419","author":"Serwold","year":"2002","journal-title":"Nature"},{"key":"10.1136\/ard-2022-222277_bib12","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ni860","article-title":"The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues","volume":"3","author":"York","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-222277_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/89800","article-title":"Er aminopeptidases generate a unique pool of peptides for MHC class I molecules","volume":"2","author":"Serwold","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-222277_bib14","doi-asserted-by":"crossref","first-page":"17594","DOI":"10.1073\/pnas.1408882111","article-title":"Functionally distinct ERAP1 allotype combinations distinguish individuals with ankylosing spondylitis","volume":"111","author":"Reeves","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2022-222277_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100443","article-title":"Common allotypes of ER aminopeptidase 1 have substrate-dependent and highly variable enzymatic properties","volume":"296","author":"Hutchinson","year":"2021","journal-title":"J Biol Chem"},{"key":"10.1136\/ard-2022-222277_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cei.13020","article-title":"The interplay between HLA-B27 and ERAP1\/ERAP2 aminopeptidases: from anti-viral protection to spondyloarthritis","volume":"190","author":"Vitulano","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2022-222277_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.molimm.2015.07.010","article-title":"Effects of polymorphic variation on the mechanism of endoplasmic reticulum aminopeptidase 1","volume":"67","author":"Stamogiannos","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1136\/ard-2022-222277_bib18","article-title":"Preparation of tumor antigen-loaded mature dendritic cells for immunotherapy","volume":"1","author":"Sabado","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1136\/ard-2022-222277_bib19","article-title":"Generation of human regulatory T cell clones","volume":"17","author":"Nowatzky","year":"2020","journal-title":"J Vis Exp"},{"key":"10.1136\/ard-2022-222277_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/cyto.a.23704","article-title":"OMIP-053: Identification, Classification, and Isolation of Major FoxP3 Expressing Human CD4+ Treg Subsets","volume":"95","author":"Nowatzky","year":"2019","journal-title":"Cytometry A"},{"key":"10.1136\/ard-2022-222277_bib21","doi-asserted-by":"crossref","first-page":"31.12.1","DOI":"10.1002\/cpmb.51","article-title":"Crispr\/Cas9-Mediated genome editing in Epstein-Barr virus-transformed lymphoblastoid B-cell lines","volume":"121","author":"Jiang","year":"2018","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1136\/ard-2022-222277_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jmoldx.2018.05.009","article-title":"Characterization of 108 genomic DNA reference materials for 11 human leukocyte antigen loci: a GeT-RM collaborative project","volume":"20","author":"Bettinotti","year":"2018","journal-title":"J Mol Diagn"},{"key":"10.1136\/ard-2022-222277_bib23","author":"Cavers"},{"key":"10.1136\/ard-2022-222277_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature24473","article-title":"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy","volume":"551","author":"\u0141uksza","year":"2017","journal-title":"Nature"},{"key":"10.1136\/ard-2022-222277_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jaut.2018.05.005","article-title":"Modulation of human Th17 cell responses through complement receptor 3 (CD11\u202fb\/CD18) ligation on monocyte-derived dendritic cells","volume":"92","author":"Nowatzky","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1136\/ard-2022-222277_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1136\/ard-2022-222277_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","article-title":"Cd8+ CD28- and CD8+ CD57+ T cells and their role in health and disease","volume":"134","author":"Strioga","year":"2011","journal-title":"Immunology"},{"key":"10.1136\/ard-2022-222277_bib28","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.4049\/jimmunol.177.8.5145","article-title":"High cytotoxic and specific migratory potencies of senescent CD8+ CD57+ cells in HIV-infected and uninfected individuals","volume":"177","author":"Le Priol","year":"2006","journal-title":"J Immunol"},{"key":"10.1136\/ard-2022-222277_bib29","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/nm942","article-title":"Ex vivo identification, isolation and analysis of tumor-cytolytic T cells","volume":"9","author":"Rubio","year":"2003","journal-title":"Nat Med"},{"key":"10.1136\/ard-2022-222277_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-8885-3_7","article-title":"CD107a degranulation assay to evaluate immune cell antitumor activity","volume":"1884","author":"Lorenzo-Herrero","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1136\/ard-2022-222277_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03841-4","article-title":"Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine","volume":"597","author":"Oberhardt","year":"2021","journal-title":"Nature"},{"key":"10.1136\/ard-2022-222277_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ni1286","article-title":"The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules","volume":"7","author":"Hammer","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-222277_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/ni1409","article-title":"In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides","volume":"8","author":"Hammer","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1136\/ard-2022-222277_bib34","doi-asserted-by":"crossref","first-page":"8706","DOI":"10.1073\/pnas.1407307111","article-title":"Hla-B*51 the primary risk in Beh\u00e7et disease","volume":"111","author":"Wallace","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1136\/ard-2022-222277_bib35","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/cei.13049","article-title":"Is Beh\u00e7et's disease a \u2018class 1-opathy\u2018? The role of HLA-B*51 in the pathogenesis of Beh\u00e7et's disease","volume":"191","author":"Giza","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2022-222277_bib36","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1002\/art.20597","article-title":"Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Beh\u00e7et's disease","volume":"50","author":"Yasuoka","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2022-222277_bib37","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.4049\/jimmunol.175.9.6133","article-title":"CD8brightCD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis","volume":"175","author":"Ahn","year":"2005","journal-title":"J Immunol"},{"key":"10.1136\/ard-2022-222277_bib38","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1167\/iovs.04-0792","article-title":"Down-Regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine\/prednisone treatment in patients with Beh\u00e7et's uveitis","volume":"46","author":"Ahn","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1136\/ard-2022-222277_bib39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1365-2249.2004.02536.x","article-title":"The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Beh\u00e7et's uveitis","volume":"137","author":"Yu","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard-2022-222277_bib40","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2133.1985.tb02082.x","article-title":"Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behcet's disease","volume":"113","author":"Kaneko","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard-2022-222277_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1365-2133.1995.tb16946.x","article-title":"Immunohistology of skin pathergy reaction in Beh\u00e7et's disease","volume":"132","author":"G\u00fcl","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1136\/ard-2022-222277_bib42","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.4049\/jimmunol.177.9.6415","article-title":"Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers","volume":"177","author":"Melikoglu","year":"2006","journal-title":"J Immunol"},{"key":"10.1136\/ard-2022-222277_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jdv.12054","article-title":"Immunopathogenic characterization of cutaneous inflammation in Beh\u00e7et's disease","volume":"28","author":"Cho","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1136\/ard-2022-222277_bib44","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2230.2011.04159.x","article-title":"Granulysin-producing cytotoxic T cells in the mucocutaneous lesions of Beh\u00e7et disease: a distinct inflammatory response from erythema nodosum","volume":"36","author":"Yamasaki","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1136\/ard-2022-222277_bib45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/art.39430","article-title":"The peptidome of Beh\u00e7et's disease-associated HLA-B*51:01 includes two Subpeptidomes differentially shaped by endoplasmic reticulum aminopeptidase 1","volume":"68","author":"Guasp","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2022-222277_bib46","doi-asserted-by":"crossref","first-page":"9680","DOI":"10.1074\/jbc.M117.789180","article-title":"The Beh\u00e7et's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing","volume":"292","author":"Guasp","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1136\/ard-2022-222277_bib47","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1074\/mcp.RA119.001515","article-title":"Redundancy and complementarity between ERAP1 and ERAP2 revealed by their effects on the Behcet's disease-associated HLA-B*51 peptidome","volume":"18","author":"Guasp","year":"2019","journal-title":"Mol Cell Proteomics"},{"key":"10.1136\/ard-2022-222277_bib48","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1074\/mcp.RA119.001617","article-title":"Identification of an unconventional subpeptidome bound to the Beh\u00e7et's disease-associated HLA-B*51:01 that is regulated by endoplasmic reticulum aminopeptidase 1 (ERAP1)","volume":"19","author":"Chen","year":"2020","journal-title":"Mol Cell Proteomics"},{"key":"10.1136\/ard-2022-222277_bib49","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.1003337","article-title":"Cutting edge: coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic peptide generation in vitro by influencing basic enzymatic properties of the enzyme","volume":"186","author":"Evnouchidou","year":"2011","journal-title":"J Immunol"},{"key":"10.1136\/ard-2022-222277_bib50","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ng.873","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2022-222277_bib51","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Genetic Analysis of Psoriasis C, the Wellcome Trust Case Control C","year":"2010","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2022-222277_bib52","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/mcp.M116.066241","article-title":"The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion","volume":"16","author":"Barnea","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"10.1136\/ard-2022-222277_bib53","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4049\/jimmunol.196.Supp.116.7","article-title":"ERAP1 deficiency protects HLA-B27 transgenic rats from arthritis [abstract]","volume":"196","author":"Tran","year":"2016","journal-title":"J Immunol"},{"key":"10.1136\/ard-2022-222277_bib54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4049\/jimmunol.198.Supp.146.5","article-title":"ERAP1 deficiency mitigates HLA-B27 misfolding and ER stress, and protects HLA-B27 transgenic rats from arthritis and orchitis [abstract]","volume":"198","author":"Tran","year":"2017","journal-title":"J Immunol"},{"key":"10.1136\/ard-2022-222277_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","article-title":"Hla-B27","volume":"33","author":"Bowness","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"10.1136\/ard-2022-222277_bib56","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2018-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724184014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724184014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2022-222277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T08:32:30Z","timestamp":1736065950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724184014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S0003496724184014"],"URL":"https:\/\/doi.org\/10.1136\/ard-2022-222277","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beh\u00e7et's disease risk-variant HLA-B51\/ERAP1-Hap10 alters human CD8 T cell immunity","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2022-222277","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 \u00a9 Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}